Schedule 13G ownership disclosure
Eleven Biotherapeutics, Inc.
Security class unavailable · CUSIP: 286221106
Event date: 2018-03-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,187,251
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-18-000073
- Form type
- SC 13G
- Filer
- Carisma Therapeutics Inc.
- CIK
- CIK 1485003
- Filed
- Mar 22, 2018
- Reporting period
- Mar 21, 2018
- Description
- Schedule 13G beneficial ownership